Cronos Group Appoints Bob Madore as Chief Financial Officer

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), an innovative global cannabinoid company, today announced the appointment of Bob Madore as Chief Financial Officer, effective August 9, 2021, who will succeed Jerry Barbato.

"We are pleased to add a leader of Bob's caliber to the Cronos Group team," said Kurt Schmidt, President and Chief Executive Officer of Cronos Group. "Bob brings to Cronos Group a proven track record of financial leadership spanning an impressive and diverse 30-year career. His operational capabilities and experience at high profile global consumer brands make him the ideal person to be our next CFO. We look forward to Bob playing a key role in our efforts to capitalize on growth opportunities as Cronos Group continues to execute our regional strategies and R&D and innovation work at the brand level."

Mr. Schmidt continued, "On behalf of everyone at Cronos Group, I would like to thank Jerry for his leadership and contributions to the Company. He played an instrumental role in strengthening our finance and procurement functions, driving the SAP implementation in both Canada and the U.S. and building out IT with a new focus on cyber security. His dedication and knowledge of the business have been instrumental in helping build Cronos Group into the Company it is today. I thank Jerry for his service and wish him all the best in his future endeavors."

Mr. Madore commented, "Cronos Group has built a premier portfolio of innovative products supported by a solid balance sheet, and it is an honor to join the Company at such an exciting time in its development. I look forward to working with Kurt and the management team and leveraging my background and skills to build on the Company's strong foundation and drive greater value for Cronos Group's shareholders."

Mr. Barbato said, "It has been a privilege to work with the Cronos Group team and I'm proud of all we have accomplished over the last several years. I know that under Bob's leadership and with support of the outstanding team across the organization, the Company is well positioned to lead the global cannabis industry and capture the significant opportunities ahead."

2021 Second Quarter Financial Results

In a separate release today, the Company disclosed its 2021 second quarter financial results. The Company will host a conference call with investors and analysts today at 8:30 a.m. ET to review its financial results.

About Bob Madore

Bob Madore recently served as Chief Financial Officer of American Eagle Outfitters Inc. from 2016 to 2020. Prior to that, he served in a number of key financial and operational roles at Ralph Lauren Corporation beginning in 2004 through 2016, most recently as Chief Financial Officer from April 2015 to September 2016. Before joining Ralph Lauren, Bob was Chief Financial Officer for New York & Company from 2003 to 2004, and served as Chief Operating Officer and Chief Financial Officer of FutureBrand, a division of McCann Erickson, from 2001 to 2003. Before that, he held various executive management positions at Nine West Group, Inc. from 1995 through 2000. Bob began his career in 1987 at Deloitte & Touche in audit services and worked in the firm's mergers and acquisitions practice from 1993 until 1995. Bob holds a Bachelor of Science from Southern Connecticut State University.

About Cronos Group Inc.

Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group's portfolio includes PEACE NATURALS ™, a global wellness platform, two adult-use brands, COVE ™ and Spinach ™, and three U.S. hemp-derived CBD brands, Lord Jones ™, Happy Dance ™ and PEACE+ ™. For more information about Cronos Group and its brands, please visit: thecronosgroup.com .

Forward-looking Statements

This press release may contain information that may constitute "forward-looking information" or "forward-looking statements" within the meaning of applicable Canadian and U.S. securities laws (collectively, "Forward-looking Statements"). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as "may", "will", "expect", "plan", "anticipate", "intend", "potential", "estimate", "believe" or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include the anticipated benefits to the Company of Mr. Madore's appointment as its Chief Financial Officer, the Company's ability to leverage the Company's strengths and deliver greater value for the Company's shareholders, and the Company's intention to build an international iconic brand portfolio and develop disruptive intellectual property. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 and subsequent reports on Form 10-Q, which have been filed on SEDAR and EDGAR and can be accessed at www.sedar.com and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos Group disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

Cronos Group Contact
Shayne Laidlaw
Tel: (416) 504-0004
investor.relations@thecronosgroup.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

The Conversation (0)
Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
Field of cannabis plants under bright sunlight.

Cannabis Market Update: H1 2025 in Review

The first half of 2025 played out differently than many cannabis market participants expected. Heading into the year, there was optimism that rescheduling in the US would reduce or eliminate challenges, but the industry continued to grapple with persistent federal regulatory uncertainty,... Keep Reading...
Closeup of lush green cannabis leaves.

Thailand Reverses Course on Cannabis, Moves to Recriminalize Amid Political Fallout

Thailand’s groundbreaking experiment with cannabis decriminalization is rapidly unraveling, with the government formally moving to reclassify the plant as a narcotic and ban recreational sales.The decision has sent shockwaves through an industry once projected to be worth over US$1 billion.The... Keep Reading...
Cannabis leaf over map of Australia.

A State-by-State Guide to Cannabis in Australia

Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will... Keep Reading...
Cannabis leaf on road marked with "2025," with sunlight in the background.

New Cannabis Consumption Trends, Regulatory Shifts Seen Driving Market in 2025

Understanding trends in the cannabis industry is paramount for investors eyeing a market with steady growth potential, but the landscape is complex as products and regulations continue to evolve. Consumption habits are changing as edibles, vaping and THC beverages gain traction, especially among... Keep Reading...

Latest Press Releases

Related News